San Diego (USA), September 18 (EFE) .- The United States approved the import of capsules containing marijuana extracts from Canada to prove its effectiveness in the treatment of Essential Tremor (ET) as announced by the School today of Medicine from the University of California San Diego (UCSD).
The Federal Drug Agency (DEA) validated the company Tilray, based in British Columbia, Canada, to provide this educational center with capsules of this drug (cannabidiol, CBD) and a low dose of tetrahydrocannabinol (THC) first, which are available. is strictly limited for research purposes.
In this way, the first phase of a study begins next year to investigate the safety, efficacy and pharmacological properties of cannabis for the possible treatment of the condition affecting approximately 10 million people in the United States, according to data from the International Foundation. for Essential Tremors (IETF).
This will be the first time that the tolerance and efficacy of the compound formula CBD and THC administered orally are being experienced, researchers said.
Fatta Nahab, neurologist and professor at the School of Medicine at UCSD, said that these tests are important information & # 39; will provide for the treatment of this condition, which is often confused with Parkinson's disease and particularly affects the elderly.
"If it turns out to be safe and effective, cannabis would not only serve as a new addition to the limited treatment options for these patients, but also provide scientists with new information about essential tremors," said the specialist, who makes estimates. that the results of the tests are achieved in one year.
Nahab wanted to evaluate whether it is a feasible therapy after detecting two patients who had shown some improvement after consuming this drug.
Essential tremor is a disorder of the nervous system that is characterized by the involuntary movement of every part of the body, especially the hands. It hampers all kinds of daily activities, from drinking water to binding laces.
The study will be conducted in collaboration with the Medicinal Cannabis Research Center.
"These tests are promising to discover new treatments for difficult conditions to treat," said Dr. Igor Grant, research director at the office. EFE